Welcome to our dedicated page for Reliance Global Group SEC filings (Ticker: RELI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing Reliance Global Group’s acquisition-packed disclosures can feel daunting. Each 10-K blends traditional insurance metrics with InsurTech R&D spend, goodwill from agency purchases, and complex commission accounting. If you have ever asked, “How do I read the Reliance Global Group annual report 10-K simplified?” or searched for “Reliance Global Group SEC filings explained simply,” you know the challenge.
Stock Titan solves it. Our AI-powered summaries untangle every section of the Reliance Global Group quarterly earnings report 10-Q filing, highlight segment performance, and surface integration costs in plain language. Real-time alerts track “Reliance Global Group insider trading Form 4 transactions” so you see executive stock moves seconds after EDGAR posts—perfect for those monitoring “Reliance Global Group Form 4 insider transactions real-time.” We also map 8-K triggers, making “Reliance Global Group 8-K material events explained” a one-click experience.
Need deeper insight? Compare commission trends across acquired agencies, review “Reliance Global Group proxy statement executive compensation” details, or dive into “Reliance Global Group earnings report filing analysis” with interactive charts. Our coverage spans every form—from 10-K and 10-Q to S-1 and SC 13D—updated instantly. Whether you’re “understanding Reliance Global Group SEC documents with AI” or tracking “Reliance Global Group executive stock transactions Form 4,” Stock Titan equips you with concise AI narratives, expert context, and downloadable originals, saving hours and sharpening your investment decisions.
Reliance Global Group (RELI) reported Q3 2025 results with total revenue of $2.50 million, down from $3.44 million a year ago. The company posted a net loss of $1.16 million for the quarter and a nine‑month net loss of $5.60 million, aided by a $3.03 million gain on the Fortman sale.
Balance sheet metrics improved. Cash and restricted cash were $3.50 million, working capital was about $1.60 million, and stockholders’ equity rose to $6.74 million. Long‑term debt fell to $4.65 million from $9.47 million after prepaying roughly $5.00 million using sale proceeds. Shares outstanding were 9,375,127 as of September 30, 2025, and 9,865,600 as of November 6, 2025.
RELI raised capital through a June private placement (~$2.5 million gross; $2.15 million net), an ATM program ($2.02 million net year‑to‑date), and an equity line of credit ($350,000 through quarter‑end). The Board declared a $0.03 per share one‑time cash dividend payable December 2, 2025. The company also adopted a digital asset treasury policy; digital assets had a fair value of $106,402 at quarter‑end. Revenue was concentrated, with Priority Health at 29% and BlueCross BlueShield at 25% of Q3 revenue.
White Lion Capital, LLC reports beneficial ownership of 450,000 common shares of Reliance Global Group, Inc., representing 9.77% of the outstanding common stock. The ownership consists of shares issued pursuant to a purchase agreement and is reported as sole voting and sole dispositive power by White Lion Capital. The percentage is calculated using 4,605,474 shares outstanding as disclosed in the issuer's registration materials. The filing includes a certification that the holdings were not acquired to change or influence control of the issuer and are not held in connection with any transaction having that purpose.
FAQ
What is the current stock price of Reliance Global Group (RELI)?
What is the market cap of Reliance Global Group (RELI)?
